RNA aptamers directed to discrete functional sites on a single protein structural domain H Shi, X Fan, A Sevilimedu, JT Lis Proceedings of the National Academy of Sciences 104 (10), 3742-3746, 2007 | 79 | 2007 |
Larval zebrafish model for studying the effects of valproic acid on neurodevelopment: An approach towards modeling autism S Dwivedi, R Medishetti, R Rani, A Sevilimedu, P Kulkarni, P Yogeeswari Journal of pharmacological and toxicological methods 95, 56-65, 2019 | 57 | 2019 |
An RNA aptamer that interferes with the DNA binding of the HSF transcription activator X Zhao, H Shi, A Sevilimedu, N Liachko, HCM Nelson, JT Lis Nucleic acids research 34 (13), 3755-3761, 2006 | 55 | 2006 |
TFIIB aptamers inhibit transcription by perturbing PIC formation at distinct stages A Sevilimedu, H Shi, JT Lis Nucleic acids research 36 (9), 3118-3127, 2008 | 30 | 2008 |
A DNAzyme based knockdown model for Fragile-X syndrome in zebrafish reveals a critical window for therapeutic intervention R Medishetti, R Rani, S Kavati, A Mahilkar, V Akella, U Saxena, P Kulkarni, ... Journal of Pharmacological and Toxicological Methods 101, 106656, 2020 | 11 | 2020 |
CRISPR-Cas9-induced gene knockout in zebrafish R Medishetti, K Balamurugan, K Yadavalli, R Rani, A Sevilimedu, ... STAR protocols 3 (4), 101779, 2022 | 7 | 2022 |
Magnetic nanoparticle formulation for targeted delivery of chemotherapeutic irinotecan to lungs P Kulkarni, M Rajadurai, A Sevilimedu, S Basaveni, S Yellanki, ... Drug Delivery and Translational Research 8, 1450-1459, 2018 | 7 | 2018 |
Drug REputposing using AI/ML tools - for Rare Diseases ( DREAM-RD) : A case study with Fragile X Syndrome ( FXS) K Agastheeswaramoorthy, A Sevilimedu biorxiv, 2020 | 6 | 2020 |
The known unknowns: Missing pieces in in vivo models of Fragile X syndrome P Kulkarni, A Sevilimedu Journal of Rare Diseases Research and Treatment 5 (1), 1-9, 2020 | 6 | 2020 |
Embryonic Zebrafish models using DNAzyme mediated knockdown A Sevilimedu, P Kulkarni US Patent App. 16/978,537, 2021 | 3 | 2021 |
Double PEGylation Significantly Improves Pharmacokinetic Properties of Irinotecan Containing Nanoparticles in a Zebrafish Model U Saxena, M Rajadurai, S Basaveni, S Yellanki, R Medishetti, ... Current Nanomedicine (Formerly: Recent Patents on Nanomedicine) 9 (2), 173-181, 2019 | 2 | 2019 |
An RNA aptamer to HP1/Swi6 facilitates heterochromatin formation at an ectopic locus in S.pombe R Rani, AM Yaseen, A Malwade, A Sevilimedu RNA biology 16 (6), 742-753, 2019 | 1 | 2019 |
Antibacterial Nanoparticles Based on Fluorescent 3‐Substituted Uridine Analogue ER Reddy, AM Yaseen, A Rizvi, GS Deora, S Banerjee, A Sevilimedu, ... ChemistrySelect 2 (1), 557-561, 2017 | 1 | 2017 |
Loss of FMRP affects ovarian development and behaviour through multiple pathways in a zebrafish model of fragile X syndrome R Rani, NS Sri, R Medishetti, K Chatti, A Sevilimedu Human Molecular Genetics, ddae077, 2024 | | 2024 |
Biallelic Variants in CCN2 Underlie an Autosomal Recessive Kyphomelic Dysplasia S Singh, S Danda, N Sharma, H Shah, V Madhuri, MT Altaf, NZ Padala, ... medRxiv, 2024.04. 05.24305189, 2024 | | 2024 |
Impaired ovarian development in a zebrafish fmr1 knockout model R Rani, NS Sri, R Medishetti, K Chatti, A Sevilimedu bioRxiv, 2024.02. 10.579749, 2024 | | 2024 |
An efficient and cost-effective method for directed mutagenesis at multiple dispersed sites—a case study with Omicron Spike DNA R Rani, KVL Parsa, K Chatti, A Sevilimedu Biology Methods and Protocols 8 (1), bpac037, 2023 | | 2023 |
Corrigendum to: Double PEGylation Significantly Improves Pharmacoki-netic Properties of Irinotecan Containing Nanoparticles in a Zebrafish Model U Saxena, M Rajadurai, S Basaveni, S Yellanki, R Medishetti, ... Current Nanomedicine (Formerly: Recent Patents on Nanomedicine) 11 (2), 139-139, 2021 | | 2021 |
Signals that Distinguish Noncoding RNA Scaffolds from mRNAs D Moazed, N Iglesias, A Sevilimedu, R Yu, G Jih, R Kruger, S Gygi The FASEB Journal 29, 361.2, 2015 | | 2015 |
Using RNA Aptamers that Bind TFIIB and TBP to Probe Preinitiation Complex Assembly in Vitro and in Vivo AS Veeravalli Cornell University, 2008 | | 2008 |